Evidence map›Paper›PMID 30809206›Full record

ArticleFrontiers in microbiology2019

Multiple Benefits of Plasmid-Mediated Quinolone Resistance Determinants in

Judit Domokos, Ivelina Damjanova, Katalin Kristof, Balazs Ligeti, Bela Kocsis, Dora Szabo

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Association ofInternational journal of microbiology · 2023
    Article
  5. Article
  6. Withdrawal of Colistin Reduces Incidence ofPathogens (Basel, Switzerland) · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. High Prevalence and Diversity of Cephalosporin-ResistantAntibiotics (Basel, Switzerland) · 2020
    Article
  12. OXA-48 Carbapenemase inMicroorganisms · 2020
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Judit DomokosInstitute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Ivelina DamjanovaNational Public Health Institute, Budapest, Hungary.
Katalin KristofInstitute of Laboratory Medicine, Clinical Microbiology Laboratory, Semmelweis University, Budapest, Hungary.
Balazs LigetiInstitute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Bela KocsisInstitute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Dora SzaboInstitute of Medical Microbiology, Semmelweis University, Budapest, Hungary.
Semmelweis University · HUNational Public Health and Medical Officer Service · HUPázmány Péter Catholic University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International high-risk clones of

Indexed as

gene expressioninternational clonesmulti-drug resistanceplasmid-mediated quinolone resistancewhole genome sequence analysis

Identifiers

PMID30809206
PMCPMC6379276
OpenAlexW2914767796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.